{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:26:44Z","timestamp":1777508804981,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,3,27]],"date-time":"2018-03-27T00:00:00Z","timestamp":1522108800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"AIFA - the Italian Medicines Agency, Rome, Italy","award":["Project AIFA-FARM9LBBBL"],"award-info":[{"award-number":["Project AIFA-FARM9LBBBL"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s40261-018-0642-4","type":"journal-article","created":{"date-parts":[[2018,3,27]],"date-time":"2018-03-27T01:14:52Z","timestamp":1522113292000},"page":"593-602","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Adherence to Antidepressants and Mortality in Elderly Patients with Cardiovascular Disease"],"prefix":"10.1007","volume":"38","author":[{"name":"on behalf of the Italian Group for Appropriate Drug prescription in the Elderly (I-GrADE)","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalisa","family":"Biffi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenza","family":"Scotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Rea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ersilia","family":"Lucenteforte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Chinellato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide L.","family":"Vetrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiana","family":"Vitale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nera","family":"Agabiti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet","family":"Sultana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Roberto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Mugelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Corrao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,27]]},"reference":[{"key":"642_CR1","unstructured":"Depression. A Global Public Health Concern. 2017. http:\/\/www.who.int\/mental_health\/ . Accessed 28 Sep 2017."},{"key":"642_CR2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12875-017-0648-7","volume":"18","author":"T Kingstone","year":"2017","unstructured":"Kingstone T, Burroughs H, Bartlam B, Ray M, Proctor J, Shepherd T, Bullock P, Chew-Graham CA. Developing a community-based psycho-social intervention with older people and third sector workers for anxiety and depression: a qualitative study. BMC Fam Pract. 2017;18:77.","journal-title":"BMC Fam Pract."},{"key":"642_CR3","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S0140-6736(07)61415-9","volume":"370","author":"S Moussavi","year":"2007","unstructured":"Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B. Depression, chronic disease and decrements in health. Results from the world health surveys. Lancet. 2007;370:851\u20138.","journal-title":"Lancet"},{"key":"642_CR4","doi-asserted-by":"publisher","first-page":"547","DOI":"10.2147\/PPA.S127277","volume":"11","author":"CM Goldstein","year":"2017","unstructured":"Goldstein CM, Gathright EC, Garcia S. Relationship between depression and medication adherence in cardiovascular disease: the perfect challenge for the integrated care team. Patient Prefer Adherence. 2017;11:547\u201359.","journal-title":"Patient Prefer Adherence."},{"key":"642_CR5","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1016\/j.amjmed.2008.09.010","volume":"121","author":"RM Carney","year":"2008","unstructured":"Carney RM, Freedland KE. Depression in patients with coronary heart disease. Am J Med. 2008;121:S20\u20137.","journal-title":"Am J Med"},{"key":"642_CR6","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1001\/archinte.166.5.498","volume":"166","author":"KZ Bambauer","year":"2006","unstructured":"Bambauer KZ, Adams AS, Zhang F, Minkoff N, Grande A, Weisblatt R, et al. Physician alerts to increase antidepressant adherence: fax or fiction? Arch Intern Med. 2006;166:498\u2013504.","journal-title":"Arch Intern Med"},{"key":"642_CR7","doi-asserted-by":"publisher","first-page":"91","DOI":"10.4088\/PCC.v09n0202","volume":"9","author":"VM Hunot","year":"2007","unstructured":"Hunot VM, Horne R, Leese MN, Churchill RC. A cohort study of adherence to antidepressants in primary care: the influence of antidepressant concerns and treatment preferences. Prim Care Companion J Clin Psychiatry. 2007;9:91\u20139.","journal-title":"Prim Care Companion J Clin Psychiatry."},{"key":"642_CR8","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1176\/appi.ajp.163.1.101","volume":"163","author":"M Olfson","year":"2006","unstructured":"Olfson M, Marcus SC, Tedeschi M, Wan GJ. Continuity of antidepressant treatment for adults with depression in the United States. Am J Psychiatry. 2006;163:101\u20138.","journal-title":"Am J Psychiatry"},{"key":"642_CR9","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1471-244X-9-38","volume":"9","author":"N Sawada","year":"2009","unstructured":"Sawada N, Uchida H, Suzuki T, Watanabe K, Kikuchi T, Handa T, et al. Persistence and compliance to antidepressant treatment in patients with depression: a chart review. BMC Psychiatry. 2009;9:38.","journal-title":"BMC Psychiatry."},{"key":"642_CR10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1192\/bjp.bp.111.096479","volume":"200","author":"JF Scherrer","year":"2012","unstructured":"Scherrer JF, Chrusciel T, Garfield LD, Freedland KE, Carney RM, Hauptman PJ, et al. Treatment-resistant and insufficiently treated depression and all-cause mortality following myocardial infarction. Br J Psychiatry. 2012;200:137\u201342.","journal-title":"Br J Psychiatry"},{"key":"642_CR11","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.amjmed.2010.11.015","volume":"124","author":"JF Scherrer","year":"2011","unstructured":"Scherrer JF, Garfield LD, Lustman PJ, Hauptman PJ, Chrusciel T, Zeringue A, et al. Antidepressant drug compliance: reduced risk of MI and mortality in depressed patients. Am J Med. 2011;124:318\u201324.","journal-title":"Am J Med"},{"key":"642_CR12","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1001\/jama.286.13.1621","volume":"286","author":"RC Ziegelstein","year":"2001","unstructured":"Ziegelstein RC. Depression in patients recovering from a myocardial infarction. JAMA. 2001;286:1621\u20137.","journal-title":"JAMA"},{"key":"642_CR13","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1001\/archinte.168.20.2232","volume":"168","author":"CM O\u2019Connor","year":"2008","unstructured":"O\u2019Connor CM, Jiang W, Kuchibhatla M, Mehta RH, Clary GL, Cuffe MS, Christopher EJ, Alexander JD, Califf RM, Krishnan RR. Antidepressant use, depression, and survival in patients with heart failure. Arch Intern Med. 2008;168:2232\u20137.","journal-title":"Arch Intern Med"},{"key":"642_CR14","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.ijcard.2015.11.032","volume":"203","author":"C Brouwers","year":"2016","unstructured":"Brouwers C, Christensen SB, Damen NL, et al. Antidepressant use and risk for mortality in 121,252 heart failure patients with or without a diagnosis of clinical depression. Int J Cardiol. 2016;203:867\u201373.","journal-title":"Int J Cardiol"},{"issue":"4","key":"642_CR15","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1001\/archinte.167.4.367","volume":"167","author":"A Sherwood","year":"2007","unstructured":"Sherwood A, Blumenthal JA, Trivedi R, et al. Relationship of depression to death or hospitalization in patients with heart failure. Arch Intern Med. 2007;167(4):367\u201373.","journal-title":"Arch Intern Med"},{"issue":"4","key":"642_CR16","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.ijcard.2012.03.143","volume":"167","author":"C Diez-Quevedo","year":"2013","unstructured":"Diez-Quevedo C, Lupon J, Gonzalez B, et al. Depression, antidepressants, and long-term mortality in heart failure. Int J Cardiol. 2013;167(4):1217\u201325.","journal-title":"Int J Cardiol"},{"key":"642_CR17","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1192\/bjp.bp.114.155820","volume":"206","author":"A Krivoy","year":"2015","unstructured":"Krivoy A, Balicer RD, Feldman B, Hoshen M, Zalsman G, Weizman A, Shoval G. Adherence to antidepressant therapy and mortality rates in ischaemic heart disease: cohort study. Br J Psychiatry. 2015;206:297\u2013301.","journal-title":"Br J Psychiatry"},{"issue":"10","key":"642_CR18","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.euroneuro.2017.08.428","volume":"27","author":"A Krivoy","year":"2017","unstructured":"Krivoy A, Stubbs B, Balicer RD, et al. Low adherence to antidepressants is associated with increased mortality following stroke: a large nationally representative cohort study. Eur Neuropsychopharmacol. 2017;27(10):970\u20136.","journal-title":"Eur Neuropsychopharmacol"},{"key":"642_CR19","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1093\/aje\/kwg231","volume":"158","author":"WA Ray","year":"2003","unstructured":"Ray WA. Evaluating medication effects outside of clinical trials: new-user designs. Am J Epidemiol. 2003;158:915\u201320.","journal-title":"Am J Epidemiol"},{"key":"642_CR20","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology. 2017. https:\/\/www.whocc.no\/ . Accessed 31 Aug 2017."},{"key":"642_CR21","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/pds.3650","volume":"23","author":"G Corrao","year":"2014","unstructured":"Corrao G, Ghirardi A, Segafredo G, Zambon A, Della Vedova G, Lapi F, et al. User-only design to assess drug effectiveness in clinical practice: application to bisphosphonates and secondary prevention of fractures. Pharmacoepidemiol Drug Saf. 2014;23:859\u201367.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"642_CR22","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1093\/aje\/kwn135","volume":"168","author":"S Suissa","year":"2008","unstructured":"Suissa S. Immeasurable time bias in observational studies of drug effects on mortality. Am J Epidemiol. 2008;168:329\u201335.","journal-title":"Am J Epidemiol"},{"key":"642_CR23","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s00228-009-0616-9","volume":"65","author":"J Haukka","year":"2009","unstructured":"Haukka J, Arffman M, Partonen T, Sihvo S, Elovainio M, Tiihonen J, L\u00f6nnqvist J, Keskim\u00e4ki I. Antidepressant use and mortality in Finland: a register-linkage study from a nationwide cohort. Eur J Clin Pharmacol. 2009;65:715\u201320.","journal-title":"Eur J Clin Pharmacol"},{"key":"642_CR24","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/pds.1230","volume":"15","author":"SE Andrade","year":"2006","unstructured":"Andrade SE, Kahler KH, Frech F, Chan KA. Methods for evaluation of medical adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf. 2006;15:565\u201374.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"642_CR25","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1111\/j.1365-2125.2012.04224.x","volume":"74","author":"F Lapi","year":"2012","unstructured":"Lapi F, Nicotra F, Scotti L, et al. Use of antidepressant serotoninergic medications and cardiac valvulopathy: a nested case-control study in the health improvement network (THIN) database. Br J Clin Pharmacol. 2012;74(3):536\u201344.","journal-title":"Br J Clin Pharmacol"},{"key":"642_CR26","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.jclinepi.2008.01.006","volume":"61","author":"ME Charlson","year":"2008","unstructured":"Charlson ME, Charlson RE, Peterson JC, Marinopoulos SS, Briggs WM, Hollenberg JP. The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients. J Clin Epidemiol. 2008;61:1234\u201340.","journal-title":"J Clin Epidemiol"},{"key":"642_CR27","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1093\/gerona\/glr233","volume":"67","author":"G Onder","year":"2012","unstructured":"Onder G, Liperoti R, Fialova D, Topinkova E, Tosato M, Danese P, Gallo PF, Carpenter I, Finne-Soveri H, Gindin J, Bernabei R, Landi F, SHELTER Project. Polypharmacy in nursing home in Europe: results from the SHELTER study. J Gerontol A Biol Sci Med Sci. 2012;67:698\u2013704.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"642_CR28","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1017\/S003329171400066X","volume":"44","author":"F Zimmermann-Viehoff","year":"2014","unstructured":"Zimmermann-Viehoff F, Kuehl LK, Danker-Hopfe H, Whooley MA, Otte C. Antidepressants, autonomic function and mortality in patients with coronary heart disease: data from the Heart and Soul Study. Psych Med. 2014;44:2975\u201384.","journal-title":"Psych Med."},{"key":"642_CR29","doi-asserted-by":"crossref","first-page":"132","DOI":"10.18553\/jmcp.2013.19.2.132","volume":"19","author":"AJ Selim","year":"2013","unstructured":"Selim AJ, Fincke BG, Rogers WH, Qian S, Selim BJ, Kazis LE. Guideline recommended medications: variation across Medicare Advantage plans and associated mortality. J Manag Care Pharm. 2013;19:132\u20138.","journal-title":"J Manag Care Pharm."},{"key":"642_CR30","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1007\/s11606-010-1609-1","volume":"26","author":"WH Shrank","year":"2011","unstructured":"Shrank WH, Patrick AR, Brookhart MA. Healthy user and related biases in observational studies of preventive interventions: a primer for physicians. J Gen Intern Med. 2011;26:546\u201350.","journal-title":"J Gen Intern Med"},{"issue":"11","key":"642_CR31","doi-asserted-by":"publisher","first-page":"772","DOI":"10.7326\/0003-4819-155-11-201112060-00009","volume":"155","author":"G Gartlehner","year":"2011","unstructured":"Gartlehner G, Hansen RA, Morgan LC, et al. Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis. Ann Intern Med. 2011;155(11):772\u201385.","journal-title":"Ann Intern Med"},{"key":"642_CR32","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/0470842555","volume-title":"pharmacoepidemiology","author":"BL Strom","year":"2000","unstructured":"Strom BL. Overview of automated databases in pharmacoepidemiology. In: Strom BL, editor. pharmacoepidemiology. 3rd ed. Chichester: Wiley; 2000. p. 219\u201322.","edition":"3"},{"key":"642_CR33","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1161\/01.HYP.0000222373.59104.3d","volume":"47","author":"MT Halpern","year":"2006","unstructured":"Halpern MT, Khan ZM, Schmier JK, Burnier M, Caro JJ, Cramer J, et al. Recommendations for evaluating compliance and persistence with hypertension therapy using retrospective data. Hypertension. 2006;47:1039\u201348.","journal-title":"Hypertension"},{"key":"642_CR34","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1161\/HYPERTENSIONAHA.114.04858","volume":"62","author":"G Corrao","year":"2015","unstructured":"Corrao G, Mancia G. Generating evidence from computerized healthcare utilization databases. Hypertension. 2015;62:490\u20138.","journal-title":"Hypertension"},{"issue":"12","key":"642_CR35","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1002\/pds.4093","volume":"25","author":"A Arfe","year":"2016","unstructured":"Arfe A, Nicotra F, Ghirardi A, et al. A probabilistic bias analysis for misclassified categorical exposures, with application to oral anti-hyperglycaemic drugs. Pharmacoepidemiol Drug Saf. 2016;25(12):1443\u201350.","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40261-018-0642-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-018-0642-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-018-0642-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T21:53:49Z","timestamp":1660686829000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40261-018-0642-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,27]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["642"],"URL":"https:\/\/doi.org\/10.1007\/s40261-018-0642-4","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,27]]},"assertion":[{"value":"27 March 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This study was funded by a research grant from the AIFA\u2014the Italian Medicines Agency\u2014(AIFA, project AIFA-FARM9LBBBL), Rome, Italy. Data analyses were performed at the Laboratory of Healthcare Research & Pharmacoepidemiology, University of Milano-Bicocca with grants from the Italian Ministry of Education, University and Research (\u2019Fondo d\u2019Ateneo per la Ricerca\u2019 portion, year 2015).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"EL received research support from the Italian Agency of Drug (AIFA). AM received research support from the Italian Agency of Drug (AIFA), the Italian Ministry for University and Research (MIUR), Gilead, and Menarini. In the last two years he received personal fees as speaker\/consultant from Menarini Group, IBSA, Molteni, Angelini and Pfizer Alliance. GC received research support from the European Community (EC), the Italian Agency of Drug (AIFA), and the Italian Ministry for University and Research (MIUR). He took part to a variety of projects that were funded by pharmaceutical companies (i.e., Novartis, GSK, Roche, AMGEN and BMS). He also received honoraria as member of Advisory Board from Roche. AC received support for participation at pharmacological meetings (SIF) and honoraria as member of Advisory board on biological drugs. Other authors declare that they have no conflict of interest to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interests"}}]}}